MFIC

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Apollo Investment Corporation (Note: The input metadata listed "Midcap Financial Investment Corp," but the filing text identifies the registrant as Apollo Investment Corporation, ticker AINV) for the quarterly period ended September 30, 2020. The Company is a closed-end, externally managed business development company (BDC) and regulated investment company (RIC) that invests primarily in debt and equity of private middle-market companies.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Total investment income decreased by approximately $25.3 million (18.5%) compared to the prior year period. This was primarily driven by a decrease in interest income due to lower average portfolio yields (dropping from 9.8% to 8.4%) and a smaller income-bearing portfolio.
• Expense Reduction: Net expenses decreased by $11.1 million, largely due to lower interest and debt expenses (annualized cost of debt dropped from 5.26% to 3.36%) and reduced management fees.
• Improved Net Income: Despite lower revenue, the Net Increase in Net Assets from Operations improved by $5.4 million year-over-year, driven by significantly lower net realized and unrealized losses.
• Unrealized Gains/Losses: The Company reported a net change in unrealized losses of $8.4 million for the six months ended September 30, 2020, a significant improvement compared to $29.2 million in losses during the same period in 2019. This improvement is attributed to the stabilization of portfolio valuations following the initial market shock of the COVID-19 pandemic.
• Debt Reduction: Total debt decreased by approximately $194 million from the beginning of the fiscal year, reducing leverage.

Guidance, Outlook, and Risks

• COVID-19 Impact: Management notes that the pandemic has adversely impacted the fair value of investments and created uncertainty. While unrealized losses have decreased compared to the prior year, the Company expects continued volatility and potential further impairments if the economic downturn persists.
• LIBOR Transition: The Company faces risks related to the phase-out of LIBOR by the end of 2021. A significant portion of the portfolio and debt obligations are LIBOR-indexed, creating operational challenges and potential valuation impacts during the transition to alternative reference rates (e.g., SOFR).
• Distributions: On November 5, 2020, the Board declared a quarterly distribution of $0.31 per share and a supplemental distribution of $0.05 per share, payable January 7, 2021. The Board expects to continue declaring a base distribution of $0.31 per share plus a supplemental amount, though no assurances are given.
• Share Repurchases: The Company suspended its stock repurchase program on March 19, 2020. No shares were repurchased during the six months ended September 30, 2020.
• Legal Proceedings: The Company is a defendant in a bankruptcy proceeding involving DSI Renal Holdings. While the Company intends to vigorously defend itself, the outcome remains uncertain.

Investor Verification Checklist

• Portfolio Valuation: Verify the fair value of Level 3 investments (99.98% of the portfolio), which rely on unobservable inputs and management estimates, particularly regarding the impact of COVID-19 on specific portfolio companies like Merx Aviation and Spotted Hawk.
• Non-Accrual Status: Review the 4.9% of investments on non-accrual status (at amortized cost) to assess credit risk and potential future write-downs.
• Debt Covenants: Confirm continued compliance with the Senior Secured Facility covenants, specifically the 150% asset coverage ratio and minimum stockholders' equity requirements.
• LIBOR Exposure: Assess the Company's progress in amending loan agreements to include fallback language for the transition away from LIBOR.
• PIK Income: Monitor the ratio of Payment-in-Kind (PIK) income to total investment income, as this non-cash income must be distributed to maintain RIC status but does not provide immediate liquidity.